Therefore, ribosomal proteins, such as RPL6, RPL3, and RPS20, have differential expression levels during bacterial infection, influenza, and coronavirus infections, including COVID, thus making such transcripts potential biomarkers to distinguish patients with viral infections and normal controls. This evidence concerns the gene RPL6 and viral infectious disease.